Overview
Kejing Tang practices in Tianjin, China. Tang is highly rated in 3 conditions, according to our data. Their top areas of expertise are Leukemia, Acute Myeloid Leukemia (AML), Acute Lymphoblastic Leukemia (ALL), and Acute Promyelocytic Leukemia.
Their clinical research consists of co-authoring 75 peer reviewed articles. MediFind looks at clinical research from the past 15 years.
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Advanced
- Acute Lymphoblastic Leukemia (ALL)
- Acute Myeloid Leukemia (AML)
- LeukemiaTang isAdvanced. Learn about Leukemia.
- Experienced
- Acute Promyelocytic Leukemia
- Chronic Myelogenous Leukemia (CML)
- RUNX1 Familial Platelet Disorder
- Wilms TumorTang isExperienced. Learn about Wilms Tumor.